These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Feldman HH; Schmitt FA; Olin JT; Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971 [TBL] [Abstract][Full Text] [Related]
15. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
16. Drugs to treat Alzheimer's disease. J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):13-4. PubMed ID: 19437925 [No Abstract] [Full Text] [Related]
17. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine. Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273 [TBL] [Abstract][Full Text] [Related]
18. Neurochemical basis for symptomatic treatment of Alzheimer's disease. Francis PT; Ramírez MJ; Lai MK Neuropharmacology; 2010; 59(4-5):221-9. PubMed ID: 20156462 [TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32). Olin JT; Bhatnagar V; Reyes P; Koumaras B; Meng X; Brannan S Int J Geriatr Psychiatry; 2010 Apr; 25(4):419-26. PubMed ID: 19670390 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies. Cummings JL Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]